Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2
Author:
Open Access
- 1 April 1996
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 35 (suppl 1) , 4-12
Abstract
This review focuses on key pharmacological findings with a new NSAID, meloxicam. Unlike established NSAIDs, it preferentially inhibits inducible COX-2 in guinea-pig peritoneal macrophages and human COX-2 in COS cells. Compared with other NSAIDs, meloxicam is the most potent inhibitor of prostaglandin biosynthesis in pleural and peritoneal exudate, but only a weak inhibitor in the gastric tract and kidney. Ulcerogenicity in the rat stomach is weak in relation to anti-inflammatory potency, resulting in a high therapeutic index. Meloxicam's high anti-inflammatory potency combined with good tolerability can be explained by its preferential inhibition of COX-2. In adjuvant arthritis rats, meloxicam inhibits not only paw swelling, but also bone and cartilage destruction and systemic signs of disease. It inhibits leucocyte migration, but has no effect on leucotriene B4 or C4. Meloxicam shows a long-lasting anti-inflammatory and analgesic effect on inflammatory pain and reduces pyrogen-induced fever, but has no central nervous system effects. The pharmacokinetic profile of meloxicam in the rat is similar to that in man. Metabolites are inactiveKeywords
This publication has 35 references indexed in Scilit:
- Meloxicam: A potent inhibitor of adjuvant arthritis in the Lewis ratInflammation Research, 1995
- Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.Drug Metabolism and Disposition, 1995
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995
- Dose-response relationship for the antipyretic effect of meloxicam in an endotoxin model in catsVeterinary Research Communications, 1995
- Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.Journal of Biological Chemistry, 1993
- Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.Journal of Biological Chemistry, 1993
- Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.Journal of Biological Chemistry, 1992
- The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.Journal of Biological Chemistry, 1990
- Visceral pain reflex after pretreatment with capsaicin and morphineNaunyn-Schmiedeberg's Archives of Pharmacology, 1982